KANEKA Your partner in the world of Chirality!
'f R-HN
C0 2 H I OH
OH
C I \ J \ ^ C 0
2
R
? ? ' ^ CH3 H
3C
'*\
|^\;0
2
Η
Es$7 Ο
ο" I HorBz (RandS)
X
~t~
II
C0 2 H
NH 2 (RandS)
A n d T h e i r Derivatives KANEKA, a technologically versatile company, leading the global chiral marketplace. Providing customers with solid foundations to support new product development from laboratory and pilot plant t o full commercialization through process innovation. Te c h η ο 1 og i e s • Biotransformations, Biotechnologies • Organic chemistry
'•y?M
Manufacturing From kg to 1,000's MT • Plants for bioprocesses and chemical reactions • Multi-purpose plants and dedicated plants Penems & Carbapenems # ACE Inhibitor Intermediates HMG Co. A Reductase Inhibitor Intermediates • Anti-AIDS Drugs Intermediates D - A m i n o acids • Chiral Synthons
• ?:$
Kaneka Corporation
mi
3-2-4, Nakanoshima Kita-Ku
•'•''M
¥**yB jS^S
t?A||§ ^5$H
^Oft
Fine Chemicals Division Osaka 530-8288, Japan Tel: 06-226-5142 Fax: 06-226-5128
[email protected] www.kaneka.co.jp/finechem/ ) Kaneka Corporation
Kaneka America Corporation Pharmaceuticals Division 65 East 55th Street N e w York, N.Y. 10022 Tel: 212-705-4340 Fax: 212-705-4350
[email protected] Kaneka Pharma Europe N.V. Triomflaan 173 I 160 Brussel, Belgium
Tel: Fax:
02-663-0340 02-663-0361
[email protected] tf-lf
Q y a i i t y Assurance •GMP •Many DMF's filed • Producing pharmaceutical bulk & intermediates
